We thus decided to use the chemical inhibitor JMS-053, which inhibits all three PRLs (PRL1, PRL2, and PRL3) with a reported IC50 ranging from 1 to 25 μmol/L in in vitro assays on ovarian cancer cell lines (19). The gene discussed is PTP4A2; the disease is ovarian carcinoma.